I. Ugo

Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human

F. Muntoni, A. Ferlini, P. Spitali, 2007, Neuromuscular Disorders.

Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies.

Susan C. Brown, K. Bushby, F. Muntoni, 2004, The American journal of pathology.

Late onset and very mild course of Xp21 Becker type muscular dystrophy.

R. Mutani, S. Bortolotto, I. Bosone, 2001, Clinical neuropathology.

Syncoilin upregulation in muscle of patients with neuromuscular disease

Francesco Muntoni, Susan C. Brown, F. Muntoni, 2005, Muscle & nerve.

Abnormalities in α-Dystroglycan Expression in MDC1C and LGMD2I Muscular Dystrophies

Susan C. Brown, K. Bushby, F. Muntoni, 2004 .

Muscle apoptosis in humans occurs in normal and denervated muscle, but not in myotonic dystrophy, dystrophinopathies or inflammatory disease

R. Piva, A. Migheli, C. Doriguzzi, 1997, Neurogenetics.

Unusual Clinical Expression of Dystrophinopathy in a Female, Mimicking a Congenital Myopathy

C. Doriguzzi, T. Mongini, L. Palmucci, 1999, European Neurology.

Variable histological expression of dystrophinopathy in two females

E. Hoffman, C. Doriguzzi, T. Mongini, 1999, Acta Neuropathologica.